Senior insider sale
CHIEF FINANCIAL OFFICER at ALLOGENE THERAPEUTICS, INC. — senior position signals high conviction
$42.2K
24K shares
What this filing means
PARKER GEOFFREY M. plans to sell 24K shares of ALLOGENE THERAPEUTICS, INC. valued at approximately $42.2K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 2/2/2026ACC: 0001950047-26-000850
Officer· CHIEF FINANCIAL OFFICER
Since Feb 2026
24K
Shares to sell
$42.2K
Approx. market value
24K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months1
Restricted stock vesting under a registered plan
Compensation
1/31/2026
24KTotal acquired24K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
1/31/2026 | Restricted stock vesting under a registered plan Compensation | 24K | — |
| Total | 24K | ||
Planned & Completed Dispositions1
NASDAQPlanned
Units to sell
24K
Market value
$42.2K
2/2/2026
Total
Units
24K
Value
$42.2K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
2/2/2026 | 24K | $42.2K | NASDAQ | Planned |
| Total | 24K | $42.2K | ||